Roivant Sciences Revenue vs. EBITDA
| ROIV Stock | USD 12.09 0.13 1.06% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 124.8 M | Current Value 131 M | Quarterly Volatility 45.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.95 | 0.7759 |
|
|
For Roivant Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Roivant Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Roivant Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Roivant Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Roivant Sciences over time as well as its relative position and ranking within its peers.
Roivant |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 5.54 | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.227 | Return On Assets (0.18) | Return On Equity 1.2896 |
The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Roivant Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Roivant Sciences EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Roivant Sciences's current stock value. Our valuation model uses many indicators to compare Roivant Sciences value to that of its competitors to determine the firm's financial worth. Roivant Sciences is rated fifth in revenue category among its peers. It is currently regarded as top stock in ebitda category among its peers totaling about 34.54 of EBITDA per Revenue. At this time, Roivant Sciences' Total Revenue is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Roivant Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Roivant Revenue vs. Competition
Roivant Sciences is rated fifth in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 3.57 Billion. Roivant Sciences holds roughly 124.8 Million in revenue claiming about 4% of equities under Health Care industry.
Roivant EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Roivant Sciences |
| = | 124.8 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Roivant Sciences |
| = | 4.31 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Roivant EBITDA Comparison
Roivant Sciences is currently under evaluation in ebitda category among its peers.
Roivant Sciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Roivant Sciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Roivant Sciences will eventually generate negative long term returns. The profitability progress is the general direction of Roivant Sciences' change in net profit over the period of time. It can combine multiple indicators of Roivant Sciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.1 M | -3.9 M | |
| Operating Income | 4.2 B | 4.5 B | |
| Income Before Tax | 4.3 B | 4.5 B | |
| Total Other Income Expense Net | 11.4 M | 10.8 M | |
| Net Loss | -908.1 M | -862.7 M | |
| Net Income | 4.2 B | 4.4 B | |
| Income Tax Expense | 22.2 M | 23.3 M | |
| Net Interest Income | 111.6 M | 117.2 M | |
| Interest Income | 146.4 M | 153.7 M | |
| Net Income From Continuing Ops | 4.2 B | 4.4 B | |
| Non Operating Income Net Other | 64.9 M | 68.2 M | |
| Change To Netincome | 317.2 M | 333.1 M | |
| Net Income Per Share | 5.55 | 5.83 | |
| Income Quality | (0.18) | (0.17) | |
| Net Income Per E B T | 1.02 | 1.07 |
Roivant Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Roivant Sciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Roivant Sciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Roivant Sciences' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Roivant Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Use Investing Themes to Complement your Roivant Sciences position
In addition to having Roivant Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Single Stock ETFs Thematic Idea Now
Single Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.